Jul 2026· IEEE Transactions on Pattern Analysis and Machine Intelligence· Vol 48, pp. 14598-14613· 0 citations· 49 references
Medicine
Abstract
Multi-modal magnetic resonance imaging (MRI) plays a crucial role in brain tumor diagnosis. However, the substantial physiological sensitivity discrepancies across imaging modalities create a severe domain gap that challenges current cross-modality segmentation methods. Many unsupervised domain adaptation (UDA) approaches reduce this gap through image style translation or distribution alignment, which have shown promising results but may struggle to preserve modality-specific anatomical and pathological information. In contrast, few-shot segmentation (FSS) provides a promising alternative paradigm with strong cross-domain generalization capability, avoiding explicit domain alignment. Therefore, in this work, we propose a novel Structure-aware Attention Prototype Network (SAPNet) for cross-modality few-shot brain tumor segmentation, which fully exploits task-agnostic, multi-scale features from the large vision model. Specifically, our SAPNet consists of three main components. First, we introduce a masked support feature reconstruction (MSFR) module to encourage the network to understand anatomically meaningful structures. Second, a patch-level attention-to-prototype alignment (APA) module is proposed to adaptively balance the aggressive and conservative segmentation tendencies by cross-attention (CA) and prototype-based learning. Third, a lightweight multi-scale decoder with the contrastive embedding space is employed to enhance fine-grained pixel-level prediction. Extensive experiments on three public benchmarks, BraTS 2020, VS-SEG, and BraTS 2023 PED datasets, demonstrate that SAPNet consistently outperforms state-of-the-art UDA and FSS methods, exhibiting strong generalization and robustness.
Introduction Benefiting from its radiation-free property and excellent soft-tissue contrast, magnetic resonance imaging (MRI) has become a crucial modality for prostate cancer diagnosis. However, automatic segmentation of prostate cancer lesions in MRI is still a challenging task due to the considerable variations in l...
Bin Cai, Yun-Fu Zeng, Jiang Liu et al.· Frontiers in Physiology· 0 citations
In clinical practice, Magnetic Resonance Imaging (MRI) data frequently suffer from the absence of certain imaging modalities, which inevitably degrades predictive performance. Existing approaches typically treat different modalities as independent and non-interacting during modal feature extraction, despite the prese...
BACKGROUND
Accurate prostate segmentation in Magnetic Resonance Imaging (MRI) is crucial for clinical diagnosis and treatment. However, it remains a challenging task due to low soft-tissue contrast and structural ambiguity in the gland's appearance. While recent deep learning methods have focused on refining network st...
Yu-Long Wang, Hui Huang, Yan Ma et al.· Medical Physics (Lancaster)· 0 citations
Accurate segmentation of tumors and lesions in brain magnetic resonance imaging (MRI) is of great importance for clinical diagnosis, surgical planning, and prognosis assessment. However, brain lesions often exhibit substantial variations in size, irregular shapes, and blurred boundaries. Traditional U-Net relies on a b...
Shuo Wang, Bo Peng, Ze-Hua Peng· 2026 6th International Confe...· 0 citations
Gliomas are the most common primary malignant brain tumors, characterized by high heterogeneity, diffuse infiltration, and poor prognosis. Accurate tumor segmentation plays a fundamental role in diagnosis, treatment planning, and quantitative analysis. Although multimodal MRI provides rich anatomical and functional inf...
Meng-Yi Ju, S. Gou, Jing-Chen Jing et al.· Neural Networks· 0 citations
Evaluation on the BraTS GOAT validation dataset demonstrated that the proposed Multi-Stage Dynamic Prompt nnU-Net outperformed the baseline nnU Net across the majority of evaluated metrics and tumor subregions.
Mohammad Mahdi Danesh Pajouh, Sara Saeedi· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.